We also explored the effects of Ror2 overexpression in tumor xenograft growth, and in The Cancer Genome Atlas (TCGA) ccRCC tumor datasets to determine how Ror2 expression related to clinical outcomes. This evidence concerns the gene ROR2 and nonpapillary renal cell carcinoma.